Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRI) Return on Invested Capital (2021 - 2025)

Historic Return on Invested Capital for Biofrontera (BFRI) over the last 5 years, with Q3 2025 value amounting to 4.87%.

  • Biofrontera's Return on Invested Capital rose 71800.0% to 4.87% in Q3 2025 from the same period last year, while for Sep 2025 it was 4.87%, marking a year-over-year increase of 71800.0%. This contributed to the annual value of 2.62% for FY2024, which is 14800.0% down from last year.
  • According to the latest figures from Q3 2025, Biofrontera's Return on Invested Capital is 4.87%, which was up 71800.0% from 7.83% recorded in Q2 2025.
  • Over the past 5 years, Biofrontera's Return on Invested Capital peaked at 18.03% during Q4 2021, and registered a low of 8.04% during Q1 2024.
  • For the 5-year period, Biofrontera's Return on Invested Capital averaged around 0.17%, with its median value being 1.57% (2022).
  • Per our database at Business Quant, Biofrontera's Return on Invested Capital plummeted by -187200bps in 2022 and then soared by 125100bps in 2025.
  • Biofrontera's Return on Invested Capital (Quarter) stood at 18.03% in 2021, then crashed by -104bps to 0.69% in 2022, then tumbled by -289bps to 2.68% in 2023, then dropped by -29bps to 3.46% in 2024, then skyrocketed by 241bps to 4.87% in 2025.
  • Its Return on Invested Capital stands at 4.87% for Q3 2025, versus 7.83% for Q2 2025 and 6.62% for Q1 2025.